Transthyretin Cardiac Amyloidosis: Underrecognized in the Underrepresented

por Leedy, Douglas J., Cuddy, Sarah A.M., Cheng, Richard K.
Publicado 2023

Rhabdomyolysis in the Setting of Concomitant Use of Tafamidis, Atorvastatin, and Amiodarone

por Laird, Jessica, Falk, Rodney H., Coyle, Melissa, Cuddy, Sarah A.M.
Publicado 2020

Effect of Tafamidis on Serum Transthyretin Levels in Non-Trial Patients With Transthyretin Amyloid Cardiomyopathy

por Falk, Rodney H., Haddad, Mia, Walker, Crystal R., Dorbala, Sharmila, Cuddy, Sarah A.M.
Publicado 2021

Modeling the Cost and Health Impacts of Diagnostic Strategies in Patients with Suspected Transthyretin Cardiac Amyloidosis

por Ge, Yin, Pandya, Ankur, Cuddy, Sarah A. M., Singh, Amitoj, Singh, Avinainder, Dorbala, Sharmila
Publicado 2022

Effect of tafamidis on global longitudinal strain and myocardial work in transthyretin cardiac amyloidosis

por Giblin, Gerard T, Cuddy, Sarah A M, González-López, Esther, Sewell, Alanna, Murphy, Amanda, Dorbala, Sharmila, Falk, Rodney H
Publicado 2022